Correlation Between Genelux Common and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Genelux Common and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genelux Common and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genelux Common and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Genelux Common and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genelux Common with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genelux Common and Sonnet Biotherapeutics.

Diversification Opportunities for Genelux Common and Sonnet Biotherapeutics

-0.22

Correlation Coefficient

Genelux Common  Sonnet Biotherapeutics

Very good diversification

The 3 months correlation between Genelux and Sonnet is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Genelux Common and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Genelux Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genelux Common are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Genelux Common i.e., Genelux Common and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Genelux Common and Sonnet Biotherapeutics

Given the investment horizon of 90 days Genelux Common is expected to generate 1.22 times more return on investment than Sonnet Biotherapeutics. However, Genelux Common is 1.22 times more volatile than Sonnet Biotherapeutics Holdings. It trades about 0.17 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about 0.0 per unit of risk. If you would invest  227.00  in Genelux Common on December 20, 2024 and sell it today you would earn a total of  173.00  from holding Genelux Common or generate 76.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Genelux Common  vs.  Sonnet Biotherapeutics Holding

Genelux Common

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Genelux Common are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Genelux Common showed solid returns over the last few months and may actually be approaching a breakup point.

Sonnet Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Sonnet Biotherapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Genelux Common and Sonnet Biotherapeutics

The main advantage of trading using opposite Genelux Common and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genelux Common position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind Genelux Common and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.